Biosency

Rennes, France

BIOSENCY is a medical device company focused on developing smart healthcare solutions.

$7.5M raised

Nov 2023

Venture - Series Unknown

Top Investors

Crédit AgricoleGO CAPITALCrédit Agricole Ille and Vilaine Expansion

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Biosency raised?

Biosency has raised $7.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2023.

Who are Biosency's investors?

Biosency's investors include Crédit Agricole, GO CAPITAL, Crédit Agricole Ille and Vilaine Expansion.

Where is Biosency headquartered?

Biosency is headquartered in Rennes, France.

What does Biosency do?

BIOSENCY is a medical device company focused on developing smart healthcare solutions.

What stage is Biosency at?

Biosency is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 8, 2023.

MLA

"Biosency — Funding & Investors." VCBacked, November 8, 2023, https://www.vcbacked.co/company/biosency. Accessed June 19, 2026.

APA

VCBacked. (2023). Biosency — Funding & Investors. Retrieved June 19, 2026, from https://www.vcbacked.co/company/biosency

Wikipedia (cite web)

{{cite web |title=Biosency — Funding & Investors |url=https://www.vcbacked.co/company/biosency |website=VCBacked |access-date=June 19, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 8, 2023.